BEGIN:VCALENDAR
VERSION:2.0
PRODID:https://github.com/derhansen/sf_event_mgt
METHOD:PUBLISH
BEGIN:VEVENT
UID:602-96@www.leopoldina.org
CLASS: PUBLIC
SUMMARY:Catatonia: an under-researched and forgotten – but frequent – neuro
 psychiatric phenotype
DESCRIPTION:Catatonia is among the most mysterious and as yet poorly unders
 tood neuropsychiatric syndromes. Nevertheless, it is an under-researched an
 d virtually forgotten – but still frequent – neuropsychiatric phenotype. Ap
 pearing as a ‘psychomotor syndrome’, it reflects temporary disruption of ex
 ecutive control in the absence of any ‘classical’ motor dysfunction. Catato
 nia is typically characterized by a fluctuating course with episodic exacer
 bations and has historically been associated with schizophrenia where it is
  classified as a positive symptom. Catatonia is, however, also observed in 
 mood and substance-induced psychotic disorders, malignant neuroleptic syndr
 ome, most encephalitides, and even general medical conditions. \n\nThe prop
 osed symposium is devoted to catatonia, reminds of its historical roots and
  its position in the current classification systems, refreshes the underpin
 nings of a catatonia/catatonic sign diagnosis, and highlights recent develo
 pments in catatonia research. \n\nStephan Heckers, an expert in medical his
 tory and classification of catatonia will illuminate on this mysterious ‘ac
 ross-disease’ syndrome and its various symptoms. As a pioneer in catatonia 
 imaging, Georg Northoff will provide functional magnetic resonance data on 
 patients and, based hereon, will give putative hints of neuronal mechanisms
  at work in human catatonia. Peter Falkai will focus on the significance of
  catatonia, a variable psychomotor syndrome of executive control deficiency
 , in clinical reality today: from under-diagnosed to forgotten. Finally, Ha
 nnelore Ehrenreich will demonstrate that catatonia can be modeled in specif
 ic myelin mutant mice, all characterized by mild neuroinflammation, and tha
 t it can be treated by microglia-targeted pharmacological intervention.\n\n
 DGPPN Congress 2018From anxiety disorders to obsessive-compulsive disorder:
  The top-class scientific and further education programme of the DGPPN Cong
 ress 2018 offers a comprehensive overview of current and future development
 s in the field of mental health – with practical insights for prevention, d
 iagnosis and treatment. 15 percent of the programme will be held in English
 . The German Association for Psychiatry, Psychotherapy and Psychosomatics (
 DGPPN) is the largest scientific medical association focussing on mental he
 alth in Germany. It pools the competence of 9000 doctors and scientists in 
 the fields of psychiatry, psychotherapy and psychosomatics who work in univ
 ersity and non-university hospitals, in office-based practices and in resea
 rch.\n\nPicture: Holger Schwarz\n\nWeitere Informationen\n\nEs handelt sich
  um eine geschlossene Veranstaltung für Fachpublikum. Eine Anmeldung ist er
 forderlich (Kongressanmeldung).\n\nKontakt\n\nSlava PlatikanovaDGPPN e. V.T
 el.: (030) 2404772-13E-Mail: s.platikanova@dgppn.de
LOCATION:Berlin
DTSTAMP:20251112T170935Z
DTSTART:20181129T091500Z
DTEND:20181129T104500Z
END:VEVENT
END:VCALENDAR